Marinomed Biotech AG Sustainability Reports
Marinomed Biotech AG specializes in developing innovative therapies for respiratory and ophthalmic conditions using their proprietary Marinosolv® and Carragelose® platforms.
Sector: Health Care
Country: Austria
Exchange: Vienna Stock Exchange
ISIN: ATMARINOMED6
11 reports from 2018 to 2025
Company Profile
Marinomed Biotech AG
Marinomed Biotech AG specializes in developing innovative therapies for respiratory and ophthalmic conditions using their proprietary Marinosolv® and Carragelose® platforms.
Reports